- Report
- May 2025
- 184 Pages
Global
From €3140EUR$3,545USD£2,721GBP
€3489EUR$3,939USD£3,023GBP
- Report
- May 2025
- 194 Pages
Global
From €3140EUR$3,545USD£2,721GBP
€3489EUR$3,939USD£3,023GBP
- Report
- February 2025
- 200 Pages
Global
From €3977EUR$4,490USD£3,446GBP
- Report
- July 2025
- 194 Pages
Global
From €5182EUR$5,850USD£4,490GBP
- Report
- August 2024
- 141 Pages
Global
From €2657EUR$2,999USD£2,302GBP
- Report
- December 2024
- 152 Pages
Global
From €3499EUR$3,950USD£3,032GBP
- Report
- April 2025
- 186 Pages
Global
From €3388EUR$3,825USD£2,936GBP
€3986EUR$4,500USD£3,454GBP
- Clinical Trials
- April 2025
- 240 Pages
Global
From €2657EUR$3,000USD£2,303GBP
- Drug Pipelines
- April 2025
- 180 Pages
Global
From €2215EUR$2,500USD£1,919GBP
- Report
- May 2025
- 196 Pages
Global
From €4208EUR$4,750USD£3,646GBP
- Report
- January 2025
- 105 Pages
Global
From €3500EUR$4,233USD£3,139GBP
- Report
- May 2025
- 120 Pages
Global
From €5271EUR$5,950USD£4,567GBP
- Report
- March 2025
- 175 Pages
Global
From €3977EUR$4,490USD£3,446GBP
- Report
- June 2025
- 150 Pages
Global
From €3410EUR$3,850USD£2,955GBP
- Drug Pipelines
- April 2025
- 60 Pages
Global
From €1772EUR$2,000USD£1,535GBP
- Drug Pipelines
- June 2025
- 200 Pages
Global
From €2471EUR$2,789USD£2,141GBP
- Report
- December 2024
- 70 Pages
Global
From €3539EUR$3,995USD£3,066GBP
- Report
- May 2025
- 198 Pages
Global
From €3140EUR$3,545USD£2,721GBP
€3489EUR$3,939USD£3,023GBP
- Report
- April 2025
- 200 Pages
Global
From €3977EUR$4,490USD£3,446GBP
- Report
- July 2025
- 278 Pages
Global
From €5182EUR$5,850USD£4,490GBP

The Asthma Treatment market is composed of a variety of drugs used to treat asthma symptoms. These drugs are divided into two main categories: long-term control medications and quick-relief medications. Long-term control medications are taken daily to reduce inflammation and prevent asthma symptoms. Quick-relief medications are taken as needed to quickly relieve asthma symptoms. Common long-term control medications include inhaled corticosteroids, leukotriene modifiers, and long-acting beta-agonists. Common quick-relief medications include short-acting beta-agonists and anticholinergics.
The Asthma Treatment market is highly competitive, with many companies offering a variety of drugs. Some of the major players in the market include GlaxoSmithKline, Merck & Co., Novartis, Sanofi, and Teva Pharmaceuticals. Show Less Read more